Download PDF
Semin Neurol 2005; 25(3): 262-277
DOI: 10.1055/s-2005-917663
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Neuroparasitic Infections: Cestodes, Trematodes, and Protozoans

M. D. Walker1 , J. R. Zunt1 , 2
  • 1Department of Neurology, University of Washington School of Medicine, Seattle, Washington
  • 2Center for AIDS and STD, University of Washington School of Medicine, Seattle, Washington
Further Information

Publication History

Publication Date:
19 September 2005 (online)

    Permissions and Reprints

ABSTRACT

Parasitic infection of the nervous system can produce a variety of symptoms and signs. Because symptoms of infection are often mild or nonspecific, diagnosis can be difficult. Familiarity with basic epidemiological characteristics and distinguishing radiographic findings can increase the likelihood of detection and proper treatment of parasitic infection of the nervous system. This article discusses the clinical presentation, diagnosis, and treatment for some of the more common infections of the nervous system caused by cestodes, trematodes and protozoans: Echinococcus spp., Spirometra spp. (sparganosis), Paragonimus spp., Schistosoma spp., Trypanosoma spp., Naegleria fowlerii, Acanthamoeba histolytica, and Balamuthia mandrillaris.

KEYWORDS

Parasite - nervous system - cestodes - trematode - protozoan

REFERENCES

  • 1 Algros M P, Majo F, Bresson-Hadni S et al.. Intracerebral alveolar echinococcosis.  Infection. 2003;  31 63-65
    CrossrefPubMedGoogle Scholar
  • 2 Al Zain T J, Al-Witry S H, Khalili H M et al.. Multiple intracranial hydatidosis.  Acta Neurochir (Wien). 2002;  144 1179-1185
    CrossrefPubMedGoogle Scholar
  • 3 Lewall D B. Hydatid disease: biology, pathology, imaging and classification.  Clin Radiol. 1998;  53 863-874
    CrossrefPubMedGoogle Scholar
  • 4 Kern P, Bardonnet K, Renner E et al.. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000.  Emerg Infect Dis. 2003;  9 343-349
    CrossrefPubMedGoogle Scholar
  • 5 Bouree P. Hydatidosis: dynamics of transmission.  World J Surg. 2001;  25 4-9
    CrossrefPubMedGoogle Scholar
  • 6 Garret M, Herbsman H, Fierst S. Cytologic diagnosis of echinococcosis.  Acta Cytol. 1977;  21 553-554
    PubMedGoogle Scholar
  • 7 Farmer P M, Chatterley S, Spier N. Echinococcal cyst of the liver: diagnosis and surgical management.  Ann Clin Lab Sci. 1990;  20 385-391
    PubMedGoogle Scholar
  • 8 Gottstein B, Reichen J. Hydatid lung disease (echinococcosis/hydatidosis).  Clin Chest Med. 2002;  23 397-408
    CrossrefPubMedGoogle Scholar
  • 9 Ramadan N I, Abel Aaty H E, Mahmoud M S, El Nori A. An enzyme-linked immunoelectrotransfer blot assay for diagnosis of human cystic echinococcosis.  J Egypt Soc Parasitol. 1999;  29 849-857
    PubMedGoogle Scholar
  • 10 Jiang L, Wen H, Ito A. Immunodiagnostic differentiation of alveolar and cystic echinococcosis using ELISA test with 18-kDa antigen extracted from Echinococcus protoscoleces.  Trans R Soc Trop Med Hyg. 2001;  95 285-288
    CrossrefPubMedGoogle Scholar
  • 11 Kanwar J R, Kaushik S P, Sawhney I M et al.. Specific antibodies in serum of patients with hydatidosis recognised by immunoblotting.  J Med Microbiol. 1992;  36 46-51
    PubMedGoogle Scholar
  • 12 Gottstein B. Molecular and immunological diagnosis of echinococcosis.  Clin Microbiol Rev. 1992;  5 248-261
    PubMedGoogle Scholar
  • 13 Tuzun M, Altinors N, Arda I S, Hekimoglu B. Cerebral hydatid disease CT and MR findings.  Clin Imaging. 2002;  26 353-357
    CrossrefPubMedGoogle Scholar
  • 14 CDC .DPDx Laboratory diagnosis of parasites of public health concern. Vol. 2003: Centers for Disease Control and Prevention 2003
    Google Scholar
  • 15 el-Mufti M, Kamag A, Ibrahim H et al.. Albendazole therapy of hydatid disease: 2-year follow-up of 40 cases.  Ann Trop Med Parasitol. 1993;  87 241-246
    PubMedGoogle Scholar
  • 16 Lee K J, Bae Y T, Kim D H et al.. A seroepidemiologic survey for human sparganosis in Gangweon-do.  Korean J Parasitol. 2002;  40 177-180
    PubMedGoogle Scholar
  • 17 Landero A, Hernandez F, Abasolo M A et al.. Cerebral sparganosis caused by Spirometra mansonoides. Case report.  J Neurosurg. 1991;  75 472-474
    PubMedGoogle Scholar
  • 18 Noya O, Alarcon de Noya B, Arrechedera H et al.. Sparganum proliferum: an overview of its structure and ultrastructure.  Int J Parasitol. 1992;  22 631-640
    PubMedGoogle Scholar
  • 19 Fontan R, Beauchamp F, Beaver P C. [New helminthiases in Laos. II. Plathelminths].  Bull Soc Pathol Exot Filiales. 1975;  68 566-573
    PubMedGoogle Scholar
  • 20 Li X. Food-borne parasitic zoonoses in the People's Republic of China.  Southeast Asian J Trop Med Public Health. 1991;  22(suppl) 31-35
    PubMedGoogle Scholar
  • 21 Hughes A J, Biggs B A. Parasitic worms of the central nervous system: an Australian perspective.  Intern Med J. 2002;  32 541-553
    PubMedGoogle Scholar
  • 22 Schmid H, Watschinger H. Sparganosis in the Masailand.  Acta Trop. 1972;  29 218-230
    PubMedGoogle Scholar
  • 23 Moulinier R, Martinez E, Torres J et al.. Human proliferative sparganosis in Venezuela: report of a case.  Am J Trop Med Hyg. 1982;  31 358-363
    PubMedGoogle Scholar
  • 24 Cummings T J, Madden J F, Gray L et al.. Parasitic lesion of the insula suggesting cerebral sparganosis: case report.  Neuroradiology. 2000;  42 206-208
    CrossrefPubMedGoogle Scholar
  • 25 Gray M L, Rogers F, Little S et al.. Sparganosis in feral hogs (Sus scrofa) from Florida.  J Am Vet Med Assoc. 1999;  215 204-208
    PubMedGoogle Scholar
  • 26 Park H Y, Lee S U, Kim S H et al.. Epidemiological significance of sero-positive inhabitants against sparganum in Kangwon-do, Korea.  Yonsei Med J. 2001;  42 371-374
    PubMedGoogle Scholar
  • 27 Mastura A B, Ambu S, Hasnah O, Rosli R. Spargana infection of frogs in Malaysia.  Southeast Asian J Trop Med Public Health. 1996;  27 51-52
    PubMedGoogle Scholar
  • 28 Tsou M H, Huang T W. Pathology of subcutaneous sparganosis: report of two cases.  J Formos Med Assoc. 1993;  92 649-653
    PubMedGoogle Scholar
  • 29 Kron M A, Guderian R, Guevara A, Hidalgo A. Abdominal sparganosis in Ecuador: a case report.  Am J Trop Med Hyg. 1991;  44 146-150
    PubMedGoogle Scholar
  • 30 Rywlin A M, Beck J W, Snyder G B. Sparganosis in Florida.  Arch Dermatol. 1968;  97 425-427
    CrossrefPubMedGoogle Scholar
  • 31 Norman S H, Kreutner Jr A. Sparganosis: clinical and pathologic observations in ten cases.  South Med J. 1980;  73 297-300
    PubMedGoogle Scholar
  • 32 Taylor R L. Sparganosis in the United States. Report of a case.  Am J Clin Pathol. 1976;  66 560-564
    PubMedGoogle Scholar
  • 33 Mueller J F. Potential longevity of life history stages of Spirometra spp.  J Parasitol. 1974;  60 376-377
    PubMedGoogle Scholar
  • 34 Chang J H, Lin O S, Yeh K T. Subcutaneous sparganosis-a case report and a review of human sparganosis in Taiwan.  Kaohsiung J Med Sci. 1999;  15 567-571
    PubMedGoogle Scholar
  • 35 Pampiglione S, Fioravanti M L, Rivasi F. Human sparganosis in Italy. Case report and review of the European cases.  APMIS. 2003;  111 349-354
    CrossrefPubMedGoogle Scholar
  • 36 Chang K H, Chi J G, Cho S Y et al.. Cerebral sparganosis: analysis of 34 cases with emphasis on CT features.  Neuroradiology. 1992;  34 1-8
    CrossrefPubMedGoogle Scholar
  • 37 Botterel F, Bouree P. Ocular sparganosis: a case report.  J Travel Med. 2003;  10 245-246
    PubMedGoogle Scholar
  • 38 Campbell E W, Beals C. Striking eosinophilia in sparganosis.  Postgrad Med. 1977;  62 138-140
    PubMedGoogle Scholar
  • 39 Fan K J, Pezeshkpour G H. Cerebral sparganosis.  Neurology. 1986;  36 1249-1251
    PubMedGoogle Scholar
  • 40 Sarma D P, Weilbaecher T G. Human sparganosis.  J Am Acad Dermatol. 1986;  15 1145-1148
    PubMedGoogle Scholar
  • 41 Nishiyama T, Ide T, Himes Jr S R et al.. Immunodiagnosis of human sparganosis mansoni by micro-chemiluminescence enzyme-linked immunosorbent assay.  Trans R Soc Trop Med Hyg. 1994;  88 663-665
    CrossrefPubMedGoogle Scholar
  • 42 Moon W K, Chang K H, Cho S Y et al.. Cerebral sparganosis: MR imaging versus CT features.  Radiology. 1993;  188 751-757
    PubMedGoogle Scholar
  • 43 Jeong S C, Bae J C, Hwang S H et al.. Cerebral sparganosis with intracerebral hemorrhage: a case report.  Neurology. 1998;  50 503-506
    PubMedGoogle Scholar
  • 44 Han S R, Park J K, Kim Y I, Son B C. Posterior cerebral artery infarction caused by cerebral sparganosis-induced vasculitis.  Eur Neurol. 2001;  46 105-107
    CrossrefPubMedGoogle Scholar
  • 45 Ishii H, Mukae H, Inoue Y et al.. A rare case of eosinophilic pleuritis due to sparganosis.  Intern Med. 2001;  40 783-785
    PubMedGoogle Scholar
  • 46 Kim D G, Paek S H, Chang K H et al.. Cerebral sparganosis: clinical manifestations, treatment, and outcome.  J Neurosurg. 1996;  85 1066-1071
    PubMedGoogle Scholar
  • 47 Torres J R, Noya O O, Noya B A et al.. Treatment of proliferative sparganosis with mebendazole and praziquantel.  Trans R Soc Trop Med Hyg. 1981;  75 846-847
    CrossrefPubMedGoogle Scholar
  • 48 Blair D, Xu Z B, Agatsuma T. Paragonimiasis and the genus Paragonimus.  Adv Parasitol. 1999;  42 113-222
    PubMedGoogle Scholar
  • 49 Kim D C. Paragonimus westermani: life cycle, intermediate hosts, transmission to man and geographical distribution in Korea.  Arzneimittelforschung. 1984;  34 1180-1183
    PubMedGoogle Scholar
  • 50 Miyazaki I, Hirose H. Immature lung flukes first found in the muscle of the wild boar in Japan.  J Parasitol. 1976;  62 836-837
    PubMedGoogle Scholar
  • 51 Choi W Y. Paragonimus westermani: pathogenesis and clinical features of infection.  Arzneimittelforschung. 1984;  34 1184-1185
    PubMedGoogle Scholar
  • 52 Oh S J. Cerebral and spinal paragonimiasis. A histopathological study.  J Neurol Sci. 1969;  9 205-236
    CrossrefPubMedGoogle Scholar
  • 53 Kusner D J, King C H. Cerebral paragonimiasis.  Semin Neurol. 1993;  13 201-208
    PubMedGoogle Scholar
  • 54 Ashitani J, Kumamoto K, Matsukura S. Paragonimiasis westermani with multifocal lesions in lungs and skin.  Intern Med. 2000;  39 433-436
    PubMedGoogle Scholar
  • 55 Kagawa F T. Pulmonary paragonimiasis.  Semin Respir Infect. 1997;  12 149-158
    PubMedGoogle Scholar
  • 56 Kang S Y, Kim T K, Kim T Y et al.. A case of chronic cerebral paragonimiasis westermani.  Korean J Parasitol. 2000;  38 167-171
    PubMedGoogle Scholar
  • 57 Kan H, Ogata T, Taniyama A et al.. Extraordinarily high eosinophilia and elevated serum interleukin-5 level observed in a patient infected with Paragonimus westermani.  Pediatrics. 1995;  96 351-354
    PubMedGoogle Scholar
  • 58 Kim T Y, Joo I J, Kang S Y et al.. Recombinant Paragonimus westermani yolk ferritin is a useful serodiagnostic antigen.  J Infect Dis. 2002;  185 1373-1375
    CrossrefPubMedGoogle Scholar
  • 59 Oh S J. Paragonimus meningitis.  J Neurol Sci. 1968;  6 419-433
    CrossrefPubMedGoogle Scholar
  • 60 Yoshida M, Moritaka K, Kuga S, Anegawa S. CT findings of cerebral paragonimiasis in the chronic state.  J Comput Assist Tomogr. 1982;  6 195-196
    PubMedGoogle Scholar
  • 61 Udaka F, Okuda B, Okada M et al.. CT findings of cerebral paragonimiasis in the chronic state.  Neuroradiology. 1988;  30 31-34
    CrossrefPubMedGoogle Scholar
  • 62 El-Garem A A. Schistosomiasis.  Digestion. 1998;  59 589-605
    CrossrefPubMedGoogle Scholar
  • 63 Pittella J E. Neuroschistosomiasis.  Brain Pathol. 1997;  7 649-662
    CrossrefPubMedGoogle Scholar
  • 64 Zheng J, Gu X G, Xu Y L et al.. Relationship between the transmission of schistosomiasis japonica and the construction of the Three Gorge Reservoir.  Acta Trop. 2002;  82 147-156
    PubMedGoogle Scholar
  • 65 Babiker S M, Blankespoor H D, Wassila M et al.. Transmission of Schistosoma haematobium in North Gezira, Sudan.  J Trop Med Hyg. 1985;  88 65-73
    PubMedGoogle Scholar
  • 66 Liu L X. Spinal and cerebral schistosomiasis.  Semin Neurol. 1993;  13 189-200
    PubMedGoogle Scholar
  • 67 Pollner J H, Schwartz A, Kobrine A, Parenti D M. Cerebral schistosomiasis caused by Schistosoma haematobium: case report.  Clin Infect Dis. 1994;  18 354-357
    CrossrefPubMedGoogle Scholar
  • 68 Haedicke T A. Cerebral schistosomiasis. A report of 10 cases caused by Schistosomiasis japonica.  Minn Med. 1972;  55 1105-1114
    PubMedGoogle Scholar
  • 69 Pittella J E. The relation between involvement of the central nervous system in schistosomiasis mansoni and the clinical forms of the parasitosis. A review.  J Trop Med Hyg. 1991;  94 15-21
    PubMedGoogle Scholar
  • 70 Scrimgeour E M, Gajdusek D C. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review.  Brain. 1985;  108 1023-1038
    CrossrefPubMedGoogle Scholar
  • 71 File S. Interaction of schistosome eggs with vascular endothelium.  J Parasitol. 1995;  81 234-238
    PubMedGoogle Scholar
  • 72 Stuiver P C. Acute schistosomiasis (Katayama fever).  Br Med J (Clin Res Ed). 1984;  288 221-222
    PubMedGoogle Scholar
  • 73 King C H, Mahmoud A A. Drugs five years later: praziquantel.  Ann Intern Med. 1989;  110 290-296
    PubMedGoogle Scholar
  • 74 Jukes M C, Nokes C A, Alcock K J et al.. Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren.  Trop Med Int Health. 2002;  7 104-117
    PubMedGoogle Scholar
  • 75 Brinkmann U K, Powollik W, Werler C, Traore M. An evaluation of sampling methods within communities and the validity of parasitological examination techniques in the field.  Trop Med Parasitol. 1988;  39 162-166
    PubMedGoogle Scholar
  • 76 Ferrari T C, Moreira P R, Oliveira R C et al.. The value of an enzyme-linked immunosorbent assay for the diagnosis of schistosomiasis mansoni myeloradiculopathy.  Trans R Soc Trop Med Hyg. 1995;  89 496-500
    CrossrefPubMedGoogle Scholar
  • 77 Gjerde I O, Mork S, Larsen J L et al.. Cerebral schistosomiasis presenting as a brain tumor.  Eur Neurol. 1984;  23 229-236
    PubMedGoogle Scholar
  • 78 Fowler R, Lee C, Keystone J S. The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion.  Am J Trop Med Hyg. 1999;  61 47-50
    PubMedGoogle Scholar
  • 79 Ching H T, Clark A E, Hendrix V J et al.. MR imaging appearance of intracerebral schistosomiasis.  AJR Am J Roentgenol. 1994;  162 693-694
    PubMedGoogle Scholar
  • 80 Preidler K W, Riepl T, Szolar D, Ranner G. Cerebral schistosomiasis: MR and CT appearance.  AJNR Am J Neuroradiol. 1996;  17 1598-1600
    PubMedGoogle Scholar
  • 81 Kardaman M W, Amin M A, Fenwick A et al.. A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan.  Ann Trop Med Parasitol. 1983;  77 297-304
    PubMedGoogle Scholar
  • 82 Watt G, Adapon B, Long G W et al.. Praziquantel in treatment of cerebral schistosomiasis.  Lancet. 1986;  2 529-532
    PubMedGoogle Scholar
  • 83 Ferrari M L, Coelho P M, Antunes C M et al.. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.  Bull World Health Organ. 2003;  81 190-196
    PubMedGoogle Scholar
  • 84 Xiao S, Tanner M, N'Goran E K et al.. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia.  Acta Trop. 2002;  82 175-181
    PubMedGoogle Scholar
  • 85 Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries.  Mem Inst Oswaldo Cruz. 2003;  98 577-591
    PubMedGoogle Scholar
  • 86 Busch M P, Kleinman S H, Nemo G J. Current and emerging infectious risks of blood transfusions.  JAMA. 2003;  289 959-962
    CrossrefPubMedGoogle Scholar
  • 87 Dias J C, Silveira A C, Schofield C J. The impact of Chagas disease control in Latin America: a review.  Mem Inst Oswaldo Cruz. 2002;  97 603-612
    PubMedGoogle Scholar
  • 88 Leiby D A, Herron Jr R M, Read E J et al.. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission.  Transfusion. 2002;  42 549-555
    CrossrefPubMedGoogle Scholar
  • 89 Sanchez-Guillen M C, Barnabe C, Guegan J F et al.. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico.  Mem Inst Oswaldo Cruz. 2002;  97 947-952
    PubMedGoogle Scholar
  • 90 Leiguarda R, Roncoroni A, Taratuto A L et al.. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients.  Neurology. 1990;  40 850-851
    PubMedGoogle Scholar
  • 91 Kirk M L, Schofield C J. Density-dependent timing of defaecation by Rhodnius prolixus, and its implications for the transmission of Trypanosoma cruzi.  Trans R Soc Trop Med Hyg. 1987;  81 348-349
    CrossrefPubMedGoogle Scholar
  • 92 Hall B F, Joiner K A. Developmentally-regulated virulence factors of Trypanosoma cruzi and their relationship to evasion of host defences.  J Eukaryot Microbiol. 1993;  40 207-213
    PubMedGoogle Scholar
  • 93 Anez N, Carrasco H, Parada H et al.. Acute Chagas' disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study.  Am J Trop Med Hyg. 1999;  60 215-222
    PubMedGoogle Scholar
  • 94 Delaporte F. Romana's sign.  J Hist Biol. 1997;  30 357-366
    CrossrefPubMedGoogle Scholar
  • 95 Dias J C. [Cecilio Romana, Romana's sign and Chagas' disease].  Rev Soc Bras Med Trop. 1997;  30 407-413
    PubMedGoogle Scholar
  • 96 Prata A. Clinical and epidemiological aspects of Chagas disease.  Lancet Infect Dis. 2001;  1 92-100
    PubMedGoogle Scholar
  • 97 Bestetti R B, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy.  Int J Cardiol. 1997;  60 187-193
    CrossrefPubMedGoogle Scholar
  • 98 Matsumoto T K, Hoshino-Shimizu S, Nakamura P M et al.. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease.  J Clin Microbiol. 1993;  31 1486-1492
    PubMedGoogle Scholar
  • 99 Umezawa E S, Nascimento M S, Stolf A M. Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease.  Diagn Microbiol Infect Dis. 2001;  39 169-176
    CrossrefPubMedGoogle Scholar
  • 100 Di Lorenzo G A, Pagano M A, Taratuto A L et al.. Chagasic granulomatous encephalitis in immunosuppressed patients. Computed tomography and magnetic resonance imaging findings.  J Neuroimaging. 1996;  6 94-97
    PubMedGoogle Scholar
  • 101 Urbina J A. Specific treatment of Chagas disease: current status and new developments.  Curr Opin Infect Dis. 2001;  14 733-741
    PubMedGoogle Scholar
  • 102 Rodriques Coura J, de Castro S L. A critical review on Chagas disease chemotherapy.  Mem Inst Oswaldo Cruz. 2002;  97 3-24
    PubMedGoogle Scholar
  • 103 Viotti R, Vigliano C, Armenti H, Segura E. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up.  Am Heart J. 1994;  127 151-162
    CrossrefPubMedGoogle Scholar
  • 104 Cerisola J A, Neves da Silva N, Prata A et al.. [Evaluation of the efficacy of nifurtimox in chronic human chagasic infection by using xenodiagnosis (author's transl)].  Bol Chil Parasitol. 1977;  32 51-62
    PubMedGoogle Scholar
  • 105 Smith D H, Pepin J, Stich A H. Human African trypanosomiasis: an emerging public health crisis.  Br Med Bull. 1998;  54 341-355
    PubMedGoogle Scholar
  • 106 Van Nieuwenhove S, Betu-Ku-Mesu V K, Diabakana P M et al.. Sleeping sickness resurgence in the DRC: the past decade.  Trop Med Int Health. 2001;  6 335-341
    PubMedGoogle Scholar
  • 107 Welburn S C, Fevre E M, Coleman P G et al.. Sleeping sickness: a tale of two diseases.  Trends Parasitol. 2001;  17 19-24
    CrossrefPubMedGoogle Scholar
  • 108 McGovern T W, Williams W, Fitzpatrick J E et al.. Cutaneous manifestations of African trypanosomiasis.  Arch Dermatol. 1995;  131 1178-1182
    CrossrefPubMedGoogle Scholar
  • 109 Kristensson K, Mhlanga J D, Bentivoglio M. Parasites and the brain: neuroinvasion, immunopathogenesis and neuronal dysfunctions.  Curr Top Microbiol Immunol. 2002;  265 227-257
    PubMedGoogle Scholar
  • 110 Villanueva M S. Trypanosomiasis of the central nervous system.  Semin Neurol. 1993;  13 209-218
    PubMedGoogle Scholar
  • 111 Enanga B, Burchmore R J, Stewart M L, Barrett M P. Sleeping sickness and the brain.  Cell Mol Life Sci. 2002;  59 845-858
    CrossrefPubMedGoogle Scholar
  • 112 Mhlanga J D, Bentivoglio M, Kristensson K. Neurobiology of cerebral malaria and African sleeping sickness.  Brain Res Bull. 1997;  44 579-589
    CrossrefPubMedGoogle Scholar
  • 113 Lejon V, Buscher P. Stage determination and follow-up in sleeping sickness.  Med Trop (Mars). 2001;  61 355-360
    PubMedGoogle Scholar
  • 114 Gill D S, Chatha D S, del Carpio-O'Donovan R. MR imaging findings in African trypansomiasis.  AJNR Am J Neuroradiol. 2003;  24 1383-1385
    PubMedGoogle Scholar
  • 115 Nok A J. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.  Parasitol Res. 2003;  90 71-79
    CrossrefPubMedGoogle Scholar
  • 116 Matovu E, Enyaru J C, Legros D et al.. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.  Trop Med Int Health. 2001;  6 407-411
    CrossrefPubMedGoogle Scholar
  • 117 Docampo R, Moreno S N. Current chemotherapy of human African trypanosomiasis.  Parasitol Res. 2003;  90(suppl 1) S10-S13
    PubMedGoogle Scholar
  • 118 Parija S C, Jayakeerthee S R. Naegleria fowleri: a free living amoeba of emerging medical importance.  J Commun Dis. 1999;  31 153-159
    PubMedGoogle Scholar
  • 119 Gyori E. December 2002: 19-year old male with febrile illness after jet ski accident.  Brain Pathol. 2003;  13 237-239
    PubMedGoogle Scholar
  • 120 Jain R, Prabhakar S, Modi M et al.. Naegleria meningitis: a rare survival.  Neurol India. 2002;  50 470-472
    PubMedGoogle Scholar
  • 121 Barnett N D, Kaplan A M, Hopkin R J et al.. Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review.  Pediatr Neurol. 1996;  15 230-234
    CrossrefPubMedGoogle Scholar
  • 122 Martinez A J. Free-living amebic meningoencephalitides: comparative study.  Neurol Neurocir Psiquiatr. 1977;  18 391-401
    PubMedGoogle Scholar
  • 123 Carter R F. Primary amoebic meningo-encephalitis: clinical, pathological and epidemiological features of six fatal cases.  J Pathol Bacteriol. 1968;  96 1-25
    CrossrefPubMedGoogle Scholar
  • 124 Viriyavejakul P, Rochanawutanon M, Sirinavin S. Naegleria meningomyeloencephalitis.  Southeast Asian J Trop Med Public Health. 1997;  28 237-240
    PubMedGoogle Scholar
  • 125 Reveiller F L, Cabanes P A, Marciano-Cabral F. Development of a nested PCR assay to detect the pathogenic free-living amoeba Naegleria fowleri.  Parasitol Res. 2002;  88 443-450
    CrossrefPubMedGoogle Scholar
  • 126 Schumacher D J, Tien R D, Lane K. Neuroimaging findings in rare amebic infections of the central nervous system.  AJNR Am J Neuroradiol. 1995;  16 930-935
    PubMedGoogle Scholar
  • 127 Ferrante A. Free-living amoebae: pathogenicity and immunity.  Parasite Immunol. 1991;  13 31-47
    PubMedGoogle Scholar
  • 128 Loschiavo F, Ventura-Spagnolo T, Sessa E, Bramanti P. Acute primary meningoencephalitis from entamoeba Naegleria Fowleri. Report of a clinical case with a favourable outcome.  Acta Neurol (Napoli). 1993;  15 333-340
    PubMedGoogle Scholar
  • 129 Seidel J S, Harmatz P, Visvesvara G S et al.. Successful treatment of primary amebic meningoencephalitis.  N Engl J Med. 1982;  306 346-348
    PubMedGoogle Scholar
  • 130 Sell J J, Rupp F W, Orrison Jr W W. Granulomatous amebic encephalitis caused by acanthamoeba.  Neuroradiology. 1997;  39 434-436
    CrossrefPubMedGoogle Scholar
  • 131 Deol I, Robledo L, Meza A et al.. Encephalitis due to a free-living amoeba (Balamuthia mandrillaris): case report with literature review.  Surg Neurol. 2000;  53 611-616
    CrossrefPubMedGoogle Scholar
  • 132 Healy J F. Balamuthia amebic encephalitis: radiographic and pathologic findings.  AJNR Am J Neuroradiol. 2002;  23 486-489
    PubMedGoogle Scholar
  • 133 McCulley J P, Alizadeh H, Niederkorn J Y. The diagnosis and management of Acanthamoeba keratitis.  CLAO J. 2000;  26 47-51
    PubMedGoogle Scholar
  • 134 Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans.  Clin Microbiol Rev. 2003;  16 273-307
    CrossrefPubMedGoogle Scholar
  • 135 Denney C F, Iragui V J, Uber-Zak L D et al.. Amebic meningoencephalitis caused by Balamuthia mandrillaris: case report and review.  Clin Infect Dis. 1997;  25 1354-1358
    CrossrefPubMedGoogle Scholar
  • 136 Martinez A J, Visvesvara G S. Free-living, amphizoic and opportunistic amebas.  Brain Pathol. 1997;  7 583-598
    CrossrefPubMedGoogle Scholar
  • 137 Singhal T, Bajpai A, Kalra V et al.. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials.  Pediatr Infect Dis J. 2001;  20 623-627
    CrossrefPubMedGoogle Scholar

Joseph R ZuntM.D. M.P.H. 

Department of Neurology, Harborview Medical Center

Box 359775, 325 Ninth Avenue South

Seattle, WA 98104

      >